ALKERMES | 营业费用

Operating Expenses 更改 日
AbbVie USD 9.35B 1.76B 2024-03
Acadia Pharmaceuticals USD 190.62M 5.48M 2024-03
ALKERMES USD 307.06M 15.78M 2024-03
Amgen USD 6.46B 469M 2024-03
Biogen USD 1.72B 306.9M 2024-03
BioMarin Pharmaceutical USD 570.37M 61.62M 2024-03
Bristol-Myers Squibb USD 10.35B 728M 2024-03
Eli Lilly USD 6.03B 933.2M 2024-03
Gilead Sciences USD 6.88B 1.37B 2024-03
Intra Cellular Therapies USD 165.8M 401K 2024-03
Ionis Pharmaceuticals USD 269.01M 34.82M 2024-03
J&J USD 15.11B 1.46B 2024-03
Malin Corporation EUR 2.2M 800K 2023-06
Merck USD 10.02B 6.55B 2024-03
Neurocrine Biosciences USD 410M 52.4M 2024-03
Otsuka Holdings JPY 434.76B 167.77B 2024-03
Pfizer USD 10.68B 10.12B 2024-03
Regeneron Pharmaceuticals USD 2.39B 74.9M 2024-03
Vertex Pharmaceuticals USD 1.47B 29M 2024-03



ALKERMES 营业费用 - 当前值，历史数据，预测，统计，图表和经济日历 - Jun 2024.